Literature DB >> 6460734

Comparative pharmacokinetics of piperacillin in normals and in patients with renal failure.

P J De Schepper, T B Tjandramaga, A Mullie, R Verbesselt, A van Hecken, R Verberckmoes, L Verbist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6460734     DOI： 10.1093/jac/9.suppl_b.49

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Population pharmacokinetics and pharmacodynamics of piperacillin in critically ill patients during the early phase of sepsis.

Authors:  Waroonrat Sukarnjanaset; Sutep Jaruratanasirikul; Thitima Wattanavijitkul
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-08       Impact factor: 2.745

Review 2.  Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses.

Authors:  Ibrahim El-Haffaf; Jean-Alexandre Caissy; Amélie Marsot
Journal:  Clin Pharmacokinet       Date:  2021-04-20       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

4.  Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients.

Authors:  Ibrahim El-Haffaf; Romain Guilhaumou; Lionel Velly; Amélie Marsot
Journal:  Clin Pharmacokinet       Date:  2022-03-28       Impact factor: 5.577

5.  Measurement of piperacillin plasma concentrations in cancer patients with suspected infection.

Authors:  Tobias Rachow; Verena Schlüter; Sibylle Bremer-Streck; Udo Lindig; Sebastian Scholl; Peter Schlattmann; Michael Kiehntopf; Andreas Hochhaus; Marie von Lilienfeld-Toal
Journal:  Infection       Date:  2017-05-17       Impact factor: 3.553

6.  Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.

Authors:  R Wise; M Logan; M Cooper; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.

Authors:  M E Klepser; K B Patel; D P Nicolau; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Optimal design of perturbations for individual two-compartment pharmacokinetic analysis.

Authors:  Matthew S Shotwell; Minchun Zhou; William H Fissell
Journal:  J Biopharm Stat       Date:  2015-08-06       Impact factor: 1.051

Review 9.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.